NEW YORK (GenomeWeb News) — MorphoSys said today that Proteomika, a proteomics biomarker-discovery subsidiary of Progenika Biopharma, has ordered “multiple” research antibodies from its AbD Serotec business unit.
 
The agreement places Proteomika “among the largest customers for custom monoclonals services provided by AbD Serotec,” MorphoSys said, but did not disclose financial details.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.